Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1230711.RAiXOiTp6ptfZbPpHBdbHIMi3yzbX2162hndSeGkudX1Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1230711.RAiXOiTp6ptfZbPpHBdbHIMi3yzbX2162hndSeGkudX1Q130_assertion type Assertion NP1230711.RAiXOiTp6ptfZbPpHBdbHIMi3yzbX2162hndSeGkudX1Q130_head.
- NP1230711.RAiXOiTp6ptfZbPpHBdbHIMi3yzbX2162hndSeGkudX1Q130_assertion description "[BRAF inhibitor-driven ERK activity and CLL proliferation required B cell antigen receptor (BCR) activation, as inhibition of the BCR-proximal spleen tyrosine kinase (SYK) reversed ERK hyperactivation and proliferation of CLL cells from multiple patients, while inhibition of the BCR-distal Bruton tyrosine kinase had no effect.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1230711.RAiXOiTp6ptfZbPpHBdbHIMi3yzbX2162hndSeGkudX1Q130_provenance.
- NP1230711.RAiXOiTp6ptfZbPpHBdbHIMi3yzbX2162hndSeGkudX1Q130_assertion evidence source_evidence_literature NP1230711.RAiXOiTp6ptfZbPpHBdbHIMi3yzbX2162hndSeGkudX1Q130_provenance.
- NP1230711.RAiXOiTp6ptfZbPpHBdbHIMi3yzbX2162hndSeGkudX1Q130_assertion SIO_000772 25329694 NP1230711.RAiXOiTp6ptfZbPpHBdbHIMi3yzbX2162hndSeGkudX1Q130_provenance.
- NP1230711.RAiXOiTp6ptfZbPpHBdbHIMi3yzbX2162hndSeGkudX1Q130_assertion wasDerivedFrom befree-2016 NP1230711.RAiXOiTp6ptfZbPpHBdbHIMi3yzbX2162hndSeGkudX1Q130_provenance.
- NP1230711.RAiXOiTp6ptfZbPpHBdbHIMi3yzbX2162hndSeGkudX1Q130_assertion wasGeneratedBy ECO_0000203 NP1230711.RAiXOiTp6ptfZbPpHBdbHIMi3yzbX2162hndSeGkudX1Q130_provenance.